Abstract
Background:Complement activation, specially the alternative pathway, has been implicated in the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This was further corroborated with the efficacy of Avacopan, a selective...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have